Creathor Ventures

Creathor Ventures invests in technology-oriented companies in the automation of industry and business as well as the personalization and digitalization of the healthcare sector. The regional focus is on Germany and Switzerland. From its offices in Bad Homburg and Zurich, the 15-strong team currently supports over 30 technology and life science companies. Over the past 30 years, the management team has financed over 200 companies as lead or co-lead investors. More than 20 companies have been listed on international stock exchanges. Creathor Ventures currently manages a fund volume of over €230 million.

Creathor Ventures' investments include CryoTherapeutics, HeyJobs, Serinus, Ledgy, Imverse, Klara, Allthings, Haja Networks, Acousia Therapeutics, Humanoo, Blueprint Genetics, Ingrid Cloud and R3 Communications.

Their exited investments include Knip, Mila, New Republic, Bitbar, COBI, Phenex Pharmaceuticals, Kigo, Doodle, Sividon Diagnostics, Viewster, stylefruits, Toroleo and cloudControl.

Creathor Ventures' investments include CryoTherapeutics, HeyJobs, Serinus, LedgyLedgy, Imverse, Klara, Allthings, Haja Networks, Acousia Therapeutics, Humanoo, Blueprint Genetics, Ingrid Cloud and R3 Communications.

Creathor Ventures' investments include CryoTherapeutics, HeyJobs, Serinus, Ledgy, Imverse, KlaraKlara, Allthings, Haja Networks, Acousia Therapeutics, Humanoo, Blueprint Genetics, Ingrid Cloud and R3 Communications.

Their exited investments include Knip, Mila, New Republic, Bitbar, COBI, Phenex Pharmaceuticals, Kigo, Doodle, Sividon Diagnostics, Viewster, stylefruits, Toroleo and cloudControlcloudControl.

Their exited investments include Knip, Mila, New Republic, BitbarBitbar, COBI, Phenex Pharmaceuticals, Kigo, Doodle, Sividon Diagnostics, Viewster, stylefruits, Toroleo and cloudControl.